Emrah GÜNAY, Nurettin AY, Şehmus KAYA, Enver YÜKSEL, Ayhan ŞENOL

Histopathological evaluation of percutaneous renalbiopsies: A single center experience

Aim: The aim of this study was to examine the indications, demographic features and histopathological diagnosis category of renalbiopsies evaluated at the Pathology Laboratory of the University of Health Sciences Diyarbakır Gazi Yasargil Training and ResearchHospital.Materials and Methods: The information of 190 patients who underwent percutaneous renal needle biopsy between July 2017 andFebruary 2020 was obtained from the approved final pathology reports.Results: 190 biopsies were performed. 60% (n=114) and 40% (n=76) of the biopsies were native and transplant, respectively. 59.5%of the patients were male. Four of the patients were under 18 years. The mean ages of the native and transplant biopsy groupeswere 37±14, and 34±14, respectively. Proteinuria was the most common biopsy indication (79.5%).Nonspecific changes werethe most common diagnosis of the native biopsies. It was followed by focal segmental glomerulonephritis (FSGS), membranousglomerulonephritis (MGN), and IgA nephritis (IgAN). The most common secondary cause of glomerulonephritis was lupus nephritis.Acute cellular rejection was the most common diagnosis of the transplant renal biopsies.Conclusion: Proteinuria was identified as the most common indication for biopsy. In the present study, the primary glomerulardisease was FSGS while the secondary was lupus nephritis. With electron microscopic examination, it might be possible to decreasethe number of patients who cannot be definitively diagnosed histomorphologically.

PDF

___

1. Printza N, Bosdou J, Pantzaki A, et al. Percutaneous ultrasound-guided renal biopsy in children: A single centre experience. Hippokratia 2011;15:258-61.
2. Pirani CL: Evaluation of kidney biopsy specimens, In Tisher CG, Brenner BM (eds): Renal Pathology: With Clinical and Functional Correlations (2nd ed). Philadelphia, PA: Lippincott 1994;85-115.
3. Fuiano G, Mazza G, Comi N, et al. Current indications for renal biopsy: A questionnaire-based survey. Am J Kidney Dis 2000;35:448-57.
4. Piskinpasa S, Dede F, Akoglu H, et al. Clinicopathological Evaluation of the Kidney Biopsies: Our Center’s Experience. Turk Neph Dial Transpl 2012;21:167-72.
5. Rivera F, López-Gómez JM, Pérez-García R. Spanish Registry of glomerulonephritis: Frequency of renal pathology in Spain. Nephrol Dial Transplant 2002;17: 1594-602.
6. Rychlík I, Jancová E, Tesar V, et al. The Czech registry of renal biopsies. Occurrence of renal diseases in the years 1994-2000. Nephrol Dial Transplant 2004;19: 3040-9.
7. Schena FP: Survey of the Italian registry of renal biopsies. Frequency of the renal diseases for 7 consecutive years. The Italian Group of Renal Immunopathology. Nephrol Dial Transplant 1997;12: 418-26.
8. Heaf J, Løkkegaard H, Larsen S. The epidemiology and prognosis of glomerulonephritis in Denmark 1985- 1997. Nephrol Dial Transplant 1999;14:1889-97.
9. Haas M, Loupy A, Lefaucheur C, et al. The Banff 2017 Kidney Meeting Report: Revised diagnostic criteria for chronic active T cell–mediated rejection, antibodymediated rejection, and prospects for integrative endpoints for next-generation clinical trials. Am J Transplant 2018;18:293-307.
10. Richards NT, Darby S, Howie AJ, et al. Knowledge of renal histology alters patient management in over 40% of cases. Nephrol Dial Transplant 1994;9:1255-9.
11. Korbet SM. Percutaneous renal biopsy. Semin Nephrol 2002;22:254-67.
12. Stratta P, Canavese C, Marengo M, et al. Risk management of renal biopsy: 1387 cases over 30 years in a single centre. Eur J Clin Invest 2007;37:954- 63.
13. Eiro M, Katoh T, Watanabe T. Risk factors for bleeding complications in percutaneous renal biopsy. Clin Exp Nephrol 2005;9:40-5.
14. Hergesell O, Felten H, Andrassy K, et al: Safety of ultrasound-guided percutaneous renal biopsyretrospective analysis of 1090 consecutive cases. Nephrol Dial Transplant 1998;13:975-7.
15. Manno C, Strippoli GF, Arnesano L, et al. Predictors of bleeding complications in percutaneous ultrasoundguided renal biopsy. Kidney Int 2004;66:1570-7.
16. Sayarlioglu H, Erkoc R, Topal C, et al. Epidemiology of glomerulonephritis in the City of Van: Pathological findings of 129 cases. Turk Neph Dial Transpl 2005;14: 23-5.
17. Ecder SA, Kılıçaslan I, Ecder T, et al. Clinicopathological evaluation of five hundred and thirteen kidney biopsies. İst Tıp Fak Derg 2005;68:43-5.
18. Hur E, Taskin H, Bozkurt D, et al. Adult native renal biopsy experience of Ege University for 12 consecutive years. BANTAO J 2010;8:22-9.
19. Briganti EM, Dowling J, Finlay M, et al. The incidence of biopsy-proven glomerulonephritis in Australia. Nephrol Dial Transplant 2001;16:1364-67.
20. Covic A, Schiller A, Volovat C, et al. Epidemiology of renal disease in Romania: a 10 year review of two regional renal biopsy databases. Nephrol Dial Transplant 2006;21:419-24.
21. Naumovic R, Pavlovic S, Stojkovic Det al. Renal biopsy registry from a single centre in Serbia: 20 years of experience. Nephrol Dial Transplant 2009;24:877-85.
22. Wirta O, MustonenJ, Helin3 H, et al. Incidence of biopsy-proven glomerulonephritis. Nephrol Dial Transplant 2008;23:193-200.
23. Gurel A, Aygen B, Duzenci D, et al. Experience of Our Nephrology Clinic on Ultrasound Assisted Percutaneous Kidney Biopsy in Adults on Three Year Period: A Clinicopathologic Evaluation 2012;26:107-9.
24. Tekin E, Diniz G, Karadeniz T, et al. Histopathological profile of kidney biopsies: Single center, four years experience. Tepecik Egit ve Arast Hast Dergisi 2018;28:181-6.